231,000 Shares in Envista Holdings Co. (NYSE:NVST) Bought by ArrowMark Colorado Holdings LLC

ArrowMark Colorado Holdings LLC acquired a new position in shares of Envista Holdings Co. (NYSE:NVST - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 231,000 shares of the company's stock, valued at approximately $4,565,000. ArrowMark Colorado Holdings LLC owned 0.13% of Envista at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. acquired a new position in Envista in the 3rd quarter valued at about $521,000. Edgestream Partners L.P. boosted its holdings in shares of Envista by 520.2% during the third quarter. Edgestream Partners L.P. now owns 151,925 shares of the company's stock worth $3,002,000 after acquiring an additional 127,430 shares during the period. Capstone Investment Advisors LLC grew its position in shares of Envista by 18.1% in the third quarter. Capstone Investment Advisors LLC now owns 66,302 shares of the company's stock valued at $1,310,000 after purchasing an additional 10,161 shares during the last quarter. PEAK6 Investments LLC bought a new position in shares of Envista during the third quarter worth approximately $1,144,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Envista by 0.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 425,502 shares of the company's stock worth $8,408,000 after purchasing an additional 3,199 shares during the last quarter.

Envista Stock Down 1.7 %

Shares of Envista stock traded down $0.39 during midday trading on Tuesday, hitting $21.92. 751,345 shares of the company traded hands, compared to its average volume of 2,375,003. Envista Holdings Co. has a 12 month low of $15.15 and a 12 month high of $25.64. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The firm's fifty day moving average price is $19.79 and its 200-day moving average price is $18.28.

Envista (NYSE:NVST - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.03. The business had revenue of $601.00 million for the quarter, compared to analyst estimates of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. Envista's quarterly revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 EPS. As a group, equities research analysts forecast that Envista Holdings Co. will post 0.72 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on NVST shares. Wells Fargo & Company initiated coverage on Envista in a research report on Tuesday, October 8th. They set an "equal weight" rating and a $20.00 price objective on the stock. Robert W. Baird increased their target price on shares of Envista from $17.00 to $22.00 and gave the stock a "neutral" rating in a research report on Thursday, October 31st. Leerink Partners upgraded shares of Envista from an "underperform" rating to a "market perform" rating and lifted their price target for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. JPMorgan Chase & Co. downgraded Envista from an "overweight" rating to a "neutral" rating and reduced their price target for the stock from $23.00 to $16.00 in a research report on Thursday, August 8th. Finally, Evercore ISI lifted their price objective on Envista from $18.00 to $23.00 and gave the company an "outperform" rating in a report on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, Envista has a consensus rating of "Hold" and an average target price of $20.71.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.